These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 33989087)

  • 1. The multiple stakeholder approach to real-world evidence (RWE) generation: observing multidisciplinary expert consensus on quality indicators of rare disease patient registries (RDRs).
    Jandhyala R
    Curr Med Res Opin; 2021 Jul; 37(7):1249-1257. PubMed ID: 33989087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A medicine adoption model for assessing the expected effects of additional real-world evidence (RWE) at product launch.
    Jandhyala R
    Curr Med Res Opin; 2021 Sep; 37(9):1645-1655. PubMed ID: 34176383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Observing expert opinion of medical affairs pharmaceutical physicians on the value of their clinical experience to the pharmaceutical industry using the Jandhyala method.
    Jandhyala R; Rout R
    Curr Med Res Opin; 2023 Dec; 39(12):1541-1550. PubMed ID: 36632732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and Validation of the Medical Affairs Pharmaceutical Physician Value (MAPPval) Instrument.
    Jandhyala R
    Pharmaceut Med; 2022 Feb; 36(1):47-57. PubMed ID: 34994965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a definition for real-world evidence using the Jandhyala method for observing consensus opinion among medical affairs pharmaceutical physicians.
    Jandhyala R
    Curr Med Res Opin; 2023 Dec; 39(12):1551-1558. PubMed ID: 36710630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a Definition for Medical Affairs Using the Jandhyala Method for Observing Consensus Opinion Among Medical Affairs Pharmaceutical Physicians.
    Jandhyala R
    Front Pharmacol; 2022; 13():842431. PubMed ID: 35273511
    [No Abstract]   [Full Text] [Related]  

  • 7. Observed consensus on research priorities for the hypertriglyceridemia patient registry.
    Freedman S; de-Madaria E; Bruckert E; Löhr M; Rebours V; Jandhyala R
    Curr Med Res Opin; 2023 Dec; 39(12):1629-1635. PubMed ID: 37428680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nutrition care quality indicators in hospitals and nursing homes: A systematic literature review and critical appraisal of current evidence.
    Moick S; Simon J; Hiesmayr M
    Clin Nutr; 2020 Jun; 39(6):1667-1680. PubMed ID: 31447247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality indicators for responsible antibiotic use in the inpatient setting: a systematic review followed by an international multidisciplinary consensus procedure.
    Monnier AA; Schouten J; Le Maréchal M; Tebano G; Pulcini C; Stanic Benic M; Vlahovic-Palcevski V; Milanic R; Adriaenssens N; Versporten A; Huttner B; Zanichelli V; Hulscher ME; Gyssens IC;
    J Antimicrob Chemother; 2018 Jun; 73(suppl_6):vi30-vi39. PubMed ID: 29878221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real world evidence (RWE) - a disruptive innovation or the quiet evolution of medical evidence generation?
    Khosla S; White R; Medina J; Ouwens M; Emmas C; Koder T; Male G; Leonard S
    F1000Res; 2018; 7():111. PubMed ID: 30026923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measuring the quality of a childhood cancer care delivery system: assessing stakeholder agreement.
    Bradley NM; Robinson PD; Greenberg ML; Barr RD; Klassen AF; Chan YL; Greenberg CM
    Value Health; 2013 Jun; 16(4):639-46. PubMed ID: 23796299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 360-degree Delphi: addressing sociotechnical challenges of healthcare IT.
    Waldmüller H; Spreckelsen C; Rudat H; Krumm N; Rolke R; Jonas SM
    BMC Med Inform Decis Mak; 2020 Jun; 20(1):101. PubMed ID: 32503609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of an indicator set for the evaluation of the population-based integrated healthcare model 'Gesundes Kinzigtal' (Healthy Kinzigtal)].
    Geraedts M; Mehl C; Schmitz J; Siegel A; Graf E; Stelzer D; Farin-Glattacker E; Ihle P; Köster I; Dröge P; Günster C; Haas N; Gröne O; Schubert I
    Z Evid Fortbild Qual Gesundhwes; 2020 Apr; 150-152():54-64. PubMed ID: 32467041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of real-world evidence in regulatory decisions for rare diseases in the United States-Current status and future directions.
    Wu J; Wang C; Toh S; Pisa FE; Bauer L
    Pharmacoepidemiol Drug Saf; 2020 Oct; 29(10):1213-1218. PubMed ID: 32003065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rare disease registries: potential applications towards impact on development of new drug treatments.
    Jansen-van der Weide MC; Gaasterland CMW; Roes KCB; Pontes C; Vives R; Sancho A; Nikolakopoulos S; Vermeulen E; van der Lee JH
    Orphanet J Rare Dis; 2018 Sep; 13(1):154. PubMed ID: 30185208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and pilot testing of quality improvement indicators for integrated primary dementia care.
    Oostra DL; Nieuwboer MS; Olde Rikkert MGM; Perry M
    BMJ Open Qual; 2020 Jun; 9(2):. PubMed ID: 32540949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of real-world evidence in cancer drug funding decisions in Canada: a qualitative study of stakeholders' perspectives.
    Clausen M; Mighton C; Kiflen R; Sebastian A; Dai WF; Mercer RE; Beca JM; Isaranuwatchai W; Chan KKW; Bombard Y
    CMAJ Open; 2020; 8(4):E772-E778. PubMed ID: 33234584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-world evidence: perspectives on challenges, value, and alignment of regulatory and national health technology assessment data collection requirements.
    Sievers H; Joos A; Hiligsmann M
    Int J Technol Assess Health Care; 2021 Feb; 37():e40. PubMed ID: 33622423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevating the Standard of Care for Patients with Psoriasis: 'Calls to Action' from Epicensus, a Multistakeholder Pan-European Initiative.
    Koren J; Lambert JLW; Thomsen SF; McAteer H; Fabbrocini G; Corazza V; Jullien D; Augustin M; Warren RB; de Rie MA; Lazaridou E; Puig L; Guillevin L; Grosser M; Boehncke WH
    Dermatol Ther (Heidelb); 2023 Jan; 13(1):245-268. PubMed ID: 36484915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.